AMYLYX PHARMACEUTICALS, INC.Equity-NMS: AMLX
Equity-NMS: AMLX
$19
+1.44
(9:00 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$19.00
Open
$19.00
Today’s high
$19.02
Today’s low
$17.86
52W low
$11.82
52W high
$38.32
1Y
-45.43%
PE
24.16
EPS (TTM)
0.70
Shares O/S
67.78M
Market cap
1.29B
Insights
AMLX is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About AMYLYX PHARMACEUTICALS, INC.

Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate, AMX003 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS).

The Company is developing AMX0035 for other neurodegenerative diseases by leveraging knowledge and relationships in the neurodegenerative space. AMX0035 is a dual unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). Its development of antisense oligonucleotides (ASOs), including lead ASO AMX0114, which targets calpain-2 (CAPN2), a gene encoding calcium-dependent proteolytic enzyme which has been implicated in the pathogenesis of ALS and other neurodegenerative diseases. .


FAQs

Can I buy AMYLYX PHARMACEUTICALS, INC. shares in India?
How to buy AMYLYX PHARMACEUTICALS, INC. shares in India?
What is the share price of AMYLYX PHARMACEUTICALS, INC.?
What is the Market Capitalization of AMYLYX PHARMACEUTICALS, INC.?
What is the PE ratio of AMYLYX PHARMACEUTICALS, INC.?
Is AMYLYX PHARMACEUTICALS, INC. a good stock to buy?
In which sector / industry does AMYLYX PHARMACEUTICALS, INC. operate?